79209728 - IMRELIX

Information

• Trademark
• 79209728

• Source

• Serial Number

  79209728

• Registration Number

  5450609

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  March 23, 2017
  7 years ago

• Registration Date

  April 24, 2018
  6 years ago

• Transaction Date

  December 03, 2024
  2 months ago

• Status Date

  November 08, 2024
  3 months ago

• Published for Opposition Date

  February 06, 2018
  7 years ago

• Location Date

  April 24, 2018
  6 years ago

• Status Code

  709

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  TIERNEY, MARGERY

• Law Office Assigned Location Code

  M20

• Owners

  • ISR Immune System Regulation Holding AB
  • Immune System Regulation Holding AB

Case File Statements

• GS0051: Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment and prevention of viral and infectious diseases and pharmaceutical preparations for the treatment of immune dysfunction and pharmaceutical preparations for the treatment of human immunodeficiency virus
• GS0441: Information and advice relating to pharmaceutical preparations, diseases and medical conditions and treatment, namely, information and advice on-line via computer networks or the Internet and providing information relating to prevention, diagnosis and treatment of infectious diseases and information and advice relating to diagnosis and treatment of diseases and medical disorders
• GS0421: Scientific research within the medical, pharmaceutical and bacteriological area, namely, Synthetic chemistry and generation of new chemical entities based on molecular structures of macrolides and of GnRH molecules to identify specific lead drug candidates for infectious diseases. Toxicology studies and preparation of investigational new drugs (INDs) according to good laboratory practice (GLP) standard operating procedures, analysis of pharmacokinetics and metabolism of drugs and new chemical entities, preparation of pharmaceutical formulations, high-throughput screening of new chemical entities in the field of anti-viral therapeutics, and consultancy and information relating thereto, conducting of tests regarding medical applications; packaging design, designing and development of medical equipment, designing pharmaceutical and medical preparations, preparation of pharmaceutical formulations, design and development of granulation technology and tablet technology namely, selection of lead drug candidates in the field of anti-viral therapeutics based on specific molecular structures, design of pharmaceutical and medical preparations through analysis of pharmacokinetics and metbolism of drugs and new chemical entities, manufacturing of pharmaceutical formulations according to good manufacturing practice (GMP) standard operating procedures, and consultancy and information relating thereto

Case File Event Statements

• 6/8/2017 - 7 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR

• 6/13/2017 - 7 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 6/29/2017 - 7 years ago

  7 - REFUSAL PROCESSED BY MPU Type: RFRR

• 6/15/2017 - 7 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 6/17/2017 - 7 years ago

  4 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 6/19/2017 - 7 years ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 6/20/2017 - 7 years ago

  6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 6/29/2017 - 7 years ago

  8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 12/20/2017 - 7 years ago

  11 - ASSIGNED TO LIE Type: ALIE

• 12/22/2017 - 7 years ago

  12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 12/22/2017 - 7 years ago

  13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 12/28/2017 - 7 years ago

  14 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 2/6/2018 - 7 years ago

  16 - PUBLISHED FOR OPPOSITION Type: PUBO

• 4/24/2018 - 6 years ago

  17 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 7/24/2018 - 6 years ago

  18 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 8/6/2018 - 6 years ago

  19 - FINAL DISPOSITION PROCESSED Type: FIMP

• 7/14/2017 - 7 years ago

  9 - REFUSAL PROCESSED BY IB Type: RFNT

• 12/13/2017 - 7 years ago

  10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 1/17/2018 - 7 years ago

  15 - NOTICE OF PUBLICATION Type: NPUB

• 8/6/2018 - 6 years ago

  20 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 8/31/2018 - 6 years ago

  21 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO

• 2/18/2022 - 2 years ago

  24 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP

• 11/8/2024 - 3 months ago

  25 - CANCELLED SECTION 71 Type: C71T

• 10/28/2021 - 3 years ago

  23 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP

• 1/24/2019 - 6 years ago

  22 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH